Distinct pathways regulated by menin and by MLL1 in hematopoietic stem cells and developing B cells.
Mixed Lineage Leukemia (MLL1) translocations encode fusion proteins retaining the N terminus of MLL1, which interacts with the tumor suppressor, menin. This interaction is essential for leukemogenesis and thus is a promising drug target. However, wild-type MLL1 plays a critical role in sustaining he...
Main Authors: | Li, B, Gan, T, Meyerson, M, Rabbitts, T, Ernst, P |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2013
|
Similar Items
-
Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors.
by: Milne, T, et al.
Published: (2005) -
Development of an orally bioavailable selective inhibitor of the menin-MLL
by: Hai-Jing Zhong, et al.
Published: (2023-09-01) -
Characterization of the Menin-MLL Interaction as Therapeutic Cancer Target
by: Krzysztof Brzezinka, et al.
Published: (2020-01-01) -
Interaction of MLL amino terminal sequences with menin is required for transformation.
by: Caslini, C, et al.
Published: (2007) -
Cdx4 and menin co-regulate Hoxa9 expression in hematopoietic cells.
by: Jizhou Yan, et al.
Published: (2006-12-01)